Skip to main content

Spontaneous Formation of Lewy Bodies in a Rodent

  • Conference paper
  • 767 Accesses

Part of the Advances in Behavioral Biology book series (ABBI,volume 56)

Keywords

  • Tyrosine Hydroxylase
  • Lewy Body
  • Spontaneous Formation
  • Lewy Body Disease
  • Incidental Lewy Body Disease

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/0-387-28066-9_30
  • Chapter length: 9 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   309.00
Price excludes VAT (USA)
  • ISBN: 978-0-387-28066-0
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   399.99
Price excludes VAT (USA)
Hardcover Book
USD   399.99
Price excludes VAT (USA)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

4. References

  • Alam, Z.I., Daniel, S.E., et al., 1997, A generalised increase in protein carbonyls in the brain in Parkinson’s but not incidental Lewy body disease, J. Neurochem. 69:1326–1329.

    PubMed  CAS  CrossRef  Google Scholar 

  • Alam, Z.I., Jenner, A., et al., 1997, Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra, J. Neurochem. 69:1196–1203.

    PubMed  CAS  CrossRef  Google Scholar 

  • Ben-Shachar, D.Z.R., and Glinka, Y., 1995, Dopamine neurotoxicity: inhibition of mitochondrial respiration, J. Neurochem. 64:718–723.

    PubMed  CAS  CrossRef  Google Scholar 

  • Betarbet, R., Sherer, T.B., et al., 2000, Chronic systemic pesticide exposure reproduces features of Parkinson’s disease, Nat. Neurosci. 3:1301–1306.

    PubMed  CrossRef  CAS  Google Scholar 

  • Bonifati, V., Rizzu, P., et al., 2003, Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism, Science 299:256–259.

    PubMed  CrossRef  CAS  Google Scholar 

  • Bowyer, J.F., and Weiner, N., 1987, Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists, J. Pharmacol. Exp. Ther. 241:27–33.

    PubMed  CAS  Google Scholar 

  • Bunney, B.S., Aghajanian, G.K., et al., 1973, Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones, Nat. New Biol. 245:123–125.

    PubMed  CAS  Google Scholar 

  • Cass, W.A., and Zahniser, N.R., 1990, Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinine, Synapse 5:336–337.

    PubMed  CrossRef  CAS  Google Scholar 

  • Conway, K.A., Harper, J.D., et al., 1998, Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease, Nat. Med. 4:1318–1320.

    PubMed  CrossRef  CAS  Google Scholar 

  • Dexter, D.T., Carter, C.J., et al., 1989, Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease, J. Neurochem. 52:381–389.

    PubMed  CAS  Google Scholar 

  • El-Agnaf, O.M., Jakes, R., et al., 1998, Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments, FEBS Lett. 440:71–75.

    PubMed  CrossRef  CAS  Google Scholar 

  • el Mestikawy, S., Glowinski, J., et al., 1986, Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals, J. Neurochem. 46:12–22.

    PubMed  Google Scholar 

  • Finkelstein, D., Parish, C.L., Stanic, D., Borrelli, E., Drago, J., and Horne, M.K., 2001, The role of Dopamine Receptors in regulating the size of axonal arbours, In: The Basal Ganglia VII. Eds. Nicholson L. and Faull R. Kluwer Academic/Plenum Publishers. 313–322.

    Google Scholar 

  • Finkelstein, D.I., Stanic, D., et al., 2000, Axonal sprouting following lesions of the rat substantia nigra, Neuroscience 97:99–112.

    PubMed  CrossRef  CAS  Google Scholar 

  • Floor, E., and Wetzel, M.G., 1998, Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J. Neurochem. 70:268–275.

    PubMed  CAS  CrossRef  Google Scholar 

  • Gassen, M., Glinka, Y., Pinchasi, B., and Youdim, M.B., 1996, Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction, Eur. J. Pharmacol. 308:219–225.

    PubMed  CrossRef  CAS  Google Scholar 

  • Giasson, B.I., Duda, J.E., et al., 2000, Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions, Science 290:985–989.

    PubMed  CrossRef  CAS  Google Scholar 

  • Glinka, Y., Gassen, M., and Youdim, M.D., 1997, Mechanism of 6-hydroxydopamine neurotoxicity. J. Neural. Transm. Suppl. 50:55–66.

    PubMed  CAS  Google Scholar 

  • Glinka, Y., Tipton, K.F., and Youdim, M.B., 1998, Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine, Eur. J. Pharmacol. 351:121–129.

    PubMed  CrossRef  CAS  Google Scholar 

  • Glinka, Y., and Youdim, M.D., 1995, Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur. J. Pharmacol. 292:329–332.

    PubMed  CAS  Google Scholar 

  • Goedert, M., 2001, Alpha-synuclein and neurodegenerative diseases, Nat. Rev. Neurosci. 2:492–501.

    PubMed  CrossRef  CAS  Google Scholar 

  • Goldberg, M.S., and Lansbury, P.T., Jr., 2000, Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson’s disease? Nat. Cell Biol. 2:E115–E119.

    PubMed  CrossRef  CAS  Google Scholar 

  • Graham, D.G., Tiffany, S.M., et al., 1978, The toxicity of melanin precursors, J. Invest. Dermatol. 70:113–116.

    PubMed  CrossRef  CAS  Google Scholar 

  • Hashimoto, M., Hsu, L.J., et al., 1998, Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease, Brain Res. 799:301–306.

    PubMed  CrossRef  CAS  Google Scholar 

  • Hashimoto, M., Takeda, A., et al., 1999, Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease, J. Biol. Chem. 274:28849–28852.

    PubMed  CrossRef  CAS  Google Scholar 

  • Healy, D.G., Abou-Sleiman, P.M., et al., 2004, PINK, PANK, or PARK? A clinicians’ guide to familial parkinsonism, Lancet Neurol. 3:652–662.

    PubMed  CrossRef  CAS  Google Scholar 

  • Hersch, S.M., Ciliax, B.J., et al., 1995, Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents, J. Neurosci. 15:5222–237.

    PubMed  CAS  Google Scholar 

  • Hsu, L.J., Sagara, Y., et al., 2000, alpha-synuclein promotes mitochondrial deficit and oxidative stress, Am. J. Pathol. 157:401–410.

    PubMed  CAS  Google Scholar 

  • Jenner, P., 1998, Oxidative mechanisms in nigral cell death in Parkinson’s disease, Mov. Disord. 13Suppl 1:24–34.

    PubMed  Google Scholar 

  • Kanda, S., Bishop, J.F., et al., 2000, Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation, Neuroscience 97:279–284.

    PubMed  CrossRef  CAS  Google Scholar 

  • Kimmel, H.L., Joyce, A.R., et al., 2001, Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat, J. Pharmacol. Exp. Ther. 298:129–140.

    PubMed  CAS  Google Scholar 

  • Lacey, M.G., Mercuri, N.B., et al., 1987, Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta, J. Physiol. 392:397–416.

    PubMed  CAS  Google Scholar 

  • Langston, J.W., and Ballard, P.A., Jr., 1983, Parkinson’s disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, New Eng. J. Med. 309:310.

    PubMed  CAS  Google Scholar 

  • Lee, H.J., and Lee, S.J., 2002, Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells, J. Biol. Chem. 277:48976–48983.

    PubMed  CrossRef  CAS  Google Scholar 

  • Lindgren, N., Xu, Z.Q., et al., 2001, Dopamine D(2) receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum, Eur. J. Neurosci. 13:773–780.

    PubMed  CrossRef  CAS  Google Scholar 

  • Lotharius, J., Barg, S., et al., 2002, Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line, J. Biol. Chem. 277:38884–38894.

    PubMed  CrossRef  CAS  Google Scholar 

  • Lotharius, J., and Brundin, P., 2002, Pathogenesis of Parkinson’s disease: dopamine, vesicles and alpha-synuclein, Nature Rev. Neurosci. 3:932–942.

    CrossRef  CAS  Google Scholar 

  • Lotharius, J., and Brundin, P., 2002, Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson’s disease, Human Mol. Genet. 1:2395–2407.

    CrossRef  Google Scholar 

  • Maker, H.S., W.C., Silides, D.J., and Cohen, G., 1981, Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates, J. Neurochem. 36:589–593.

    PubMed  CAS  Google Scholar 

  • Narhi, L., Wood, S.J., et al., 1999, Both familial Parkinson’s disease mutations accelerate alpha-synuclein aggregation, J. Biol. Chem. 274:9843–9846.

    PubMed  CrossRef  CAS  Google Scholar 

  • Onali, P., Olianas, M.C., et al., 1988, Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes, Brain Res. 456:302–309.

    PubMed  CrossRef  CAS  Google Scholar 

  • Palacino, J.J., Sagi, D., et al., 2004, Mitochondrial dysfunction and oxidative damage in parkin-deficient mice, J. Biol. Chem. 279:18614–18622.

    PubMed  CrossRef  CAS  Google Scholar 

  • Parish, C.L., Finkelstein, D.I., et al., 2001, The role of dopamine receptors in regulating the size of axonal arbors, J. Neurosci. 21:5147–5157.

    PubMed  CAS  Google Scholar 

  • Parish, C.L., Stanic, D., et al., 2002, Effects of long-term treatment with dopamine receptor agonists and antagonists on terminal arbor size, Eur. J. Neurosci. 16:787–794.

    PubMed  CrossRef  CAS  Google Scholar 

  • Petersen, A., Puschban, Z., Lotharius, J., et al., 2002, Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington’s disease mice, Neurobiol. Dis. 11:134–146.

    PubMed  CrossRef  CAS  Google Scholar 

  • Polymeropoulos, M.H., Lavedan, C., et al., 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease, Science 276:2045–2047.

    PubMed  CrossRef  CAS  Google Scholar 

  • Robinson, M.B., 2002, Regulated trafficking of neurotransmitter transporters: common notes but different melodies, J. Neurochem. 80:1–11.

    PubMed  CrossRef  CAS  Google Scholar 

  • Saggu, H., Cooksey, J., et al., 1989, A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra, J. Neurochem. 53:692–697.

    PubMed  CAS  Google Scholar 

  • Singleton, A.B., Farrer, M., et al., 2003, alpha-Synuclein locus triplication causes Parkinson’s disease, Science 302:841.

    PubMed  CrossRef  CAS  Google Scholar 

  • Sofic, E., Riederer, P., et al., 1988, Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain, J. Neural. Transm. 74:199–205.

    PubMed  CrossRef  CAS  Google Scholar 

  • Spillantini, M.G., Crowther, R.A., et al., 1998, alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies, Proc. Natl. Acad. Sci. USA 95:6469–6473.

    PubMed  CrossRef  CAS  Google Scholar 

  • Stanic, D., Finkelstein, D.I., et al., 2003a, Time course of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat, Eur. J. Neurosci. 18:1175–1188.

    PubMed  CrossRef  CAS  Google Scholar 

  • Stanic, D., Parish, C.L., et al., 2003b, Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc, J. Neurochem. 86:329–343.

    PubMed  CrossRef  CAS  Google Scholar 

  • Tepper, J.M., Nakamura, S., et al., 1984, Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions, Brain Res. 309:317–333.

    PubMed  CrossRef  CAS  Google Scholar 

  • Tompkins, M.M., Basgall, E.J., et al., 1997, Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons, Am. J. Pathol. 150:119–131.

    PubMed  CAS  Google Scholar 

  • Tompkins, M.M., and Hill, W.D., 1997, Contribution of somal Lewy bodies to neuronal death, Brain Res. 775:24–29.

    PubMed  CrossRef  CAS  Google Scholar 

  • Ungerstedt, U., Herrera-Marschitz, M., et al., 1982, Models for studying the synaptic mechanisms: correlative measurements of transmitter release and drug altered behaviour. In: Behavioural Models and the Analysis of Drug Action. Eds: M.Y. Spiegelstein and A. Levy. Amsterdam, Elsevier: 57–70.

    Google Scholar 

  • Valente, E.M., Abou-Sleiman, P.M., et al., 2004, Hereditary early-onset Parkinson’s disease caused by mutations in PINK1, Science 304:1158–1160.

    PubMed  CrossRef  CAS  Google Scholar 

  • Xu, J., Kao, S.Y., et al., 2002, Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease, Nat. Med. 8:600–606.

    PubMed  CrossRef  CAS  Google Scholar 

  • Zhang, Y., Dawson, V.L., et al., 2000, Oxidative stress and genetics in the pathogenesis of Parkinson’s disease, Neurobiol. Dis. 7:240–250.

    PubMed  CrossRef  CAS  Google Scholar 

  • Zigmond, M., Hastings, T., et al., 2002, Increased dopamine turnover after partial loss of dopaminergic neurons: compensation or toxicity? Parkinsonism Relat. Disord. 8:389.

    PubMed  CrossRef  Google Scholar 

  • Zigmond, M.J., Abercrombie, E.D., et al., 1990, Compensations after lesions of central dopaminergic neurons: some clinical and basic implications, Trends Neurosci. 13:290–296.

    PubMed  CrossRef  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this paper

Cite this paper

Nunan, J. et al. (2005). Spontaneous Formation of Lewy Bodies in a Rodent. In: Bolam, J.P., Ingham, C.A., Magill, P.J. (eds) The Basal Ganglia VIII. Advances in Behavioral Biology, vol 56. Springer, Boston, MA. https://doi.org/10.1007/0-387-28066-9_30

Download citation